Impact of Atrial Fibrillation on Outcome in Takotsubo Syndrome: Data From the International Takotsubo Registry.
Aged
Aged, 80 and over
Atrial Fibrillation
/ diagnosis
Europe
/ epidemiology
Female
Hospital Mortality
Humans
Male
Middle Aged
Patient Admission
Prevalence
Prognosis
Prospective Studies
Registries
Retrospective Studies
Risk Assessment
Risk Factors
Takotsubo Cardiomyopathy
/ diagnosis
Time Factors
United States
/ epidemiology
Takotsubo syndrome
atrial fibrillation
broken heart syndrome
outcome
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
03 08 2021
03 08 2021
Historique:
pubmed:
29
7
2021
medline:
30
10
2021
entrez:
28
7
2021
Statut:
ppublish
Résumé
Background Atrial fibrillation (AF) is a major risk factor for mortality. The prevalence, clinical correlates, and prognostic impact of AF in Takotsubo syndrome (TTS) have not yet been investigated in a large patient cohort. This study aimed to investigate the prevalence, clinical correlates, and prognostic impact of AF in patients with TTS. Methods and Results Patients with TTS were enrolled from the International Takotsubo Registry, which is a multinational network with 26 participating centers in Europe and the United States. Patients were dichotomized according to the presence or absence of AF at the time of admission. Of 1584 patients with TTS, 112 (7.1%) had AF. The mean age was higher (
Identifiants
pubmed: 34315238
doi: 10.1161/JAHA.119.014059
pmc: PMC8475688
doi:
Banques de données
ClinicalTrials.gov
['NCT01947621']
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e014059Références
Int J Cardiol. 2018 Mar 1;254:195-202
pubmed: 29407091
Europace. 2017 Aug 1;19(8):1288-1292
pubmed: 27702871
Heart Rhythm. 2017 Jul;14(7):1073-1080
pubmed: 28185917
Circulation. 1998 Sep 8;98(10):946-52
pubmed: 9737513
J Atr Fibrillation. 2012 Jun 15;5(1):551
pubmed: 28496750
Europace. 2019 Feb 1;21(2):298-305
pubmed: 30007327
Int J Cardiol. 2017 Oct 15;245:156-161
pubmed: 28743481
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
Heart. 2017 Sep;103(18):1461-1469
pubmed: 28839096
J Mol Cell Cardiol. 2000 Mar;32(3):465-77
pubmed: 10731445
Prog Biophys Mol Biol. 2003 May-Jul;82(1-3):137-49
pubmed: 12732274
Heart Rhythm. 2015 Mar;12(3):604-609
pubmed: 25461497
Heart Lung. 2010 May-Jun;39(3):188-95
pubmed: 20457338
Eur Heart J. 2018 Jun 7;39(22):2047-2062
pubmed: 29850820
J Am Heart Assoc. 2019 Aug 20;8(16):e013638
pubmed: 31423871
J Am Coll Cardiol. 2018 Aug 21;72(8):874-882
pubmed: 30115226
Int J Cardiol. 2010 Feb 18;139(1):98-100
pubmed: 18718684
Circulation. 2011 Apr 19;123(15):1587-93
pubmed: 21464054
Eur Heart J. 2016 Oct 7;37(38):2893-2962
pubmed: 27567408
N Engl J Med. 2015 Sep 3;373(10):929-38
pubmed: 26332547
Circulation. 2015 Jan 27;131(4):e29-322
pubmed: 25520374
Atherosclerosis. 2016 Nov;254:28-34
pubmed: 27680775
Am Heart J. 2008 Mar;155(3):408-17
pubmed: 18294473
Clin Med Res. 2010 Dec;8(3-4):142-9
pubmed: 20682760
Ann Noninvasive Electrocardiol. 2019 Jan;24(1):e12566
pubmed: 29938868
Circ Arrhythm Electrophysiol. 2017 Jan;10(1):
pubmed: 28077507
Nat Rev Cardiol. 2015 Apr;12(4):230-43
pubmed: 25622848
J Clin Epidemiol. 1996 Dec;49(12):1373-9
pubmed: 8970487
Circ J. 2015;79(3):495-502
pubmed: 25746525